Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA stops notarizing device export certificates

This article was originally published in Clinica

Executive Summary

The US FDA has discontinued its practice of notarizing medical device export certificates and manufacturers will now have to apply to another government department for the authentication. At the same time, the agency is enhancing its voluntary online system for allowing manufacturers to request export documents more efficiently than submitting their applications on paper.

You may also be interested in...

Changes Coming Next Month To US FDA Web-Based Device Export Tracker

FDA plans to make major changes to the CDRH Export Certification and Tracking System that allows companies to process export submissions electronically. The agency will be holding a webinar in mid-September to prepare stakeholders.

New Filings At The EMA

New medicines under evaluation at the European Medicines Agency.

Alzheimer’s Drug & Dermatitis JAK inhibitor Among New EU Filings

Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts